These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12014596)

  • 61. Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study.
    Germinario EA; Arcieri R; Bonati M; Zuddas A; Masi G; Vella S; Chiarotti F; Panei P;
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):440-7. PubMed ID: 24024538
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ADHD, growth deficits, and relationships to psychostimulant use.
    Joshi SV
    Pediatr Rev; 2002 Feb; 23(2):67-8; discussion 67-8. PubMed ID: 11826259
    [No Abstract]   [Full Text] [Related]  

  • 63. Stimulant medication effects on growth and bone age in children with attention-deficit/hyperactivity disorder: a prospective cohort study.
    Poulton AS; Bui Q; Melzer E; Evans R
    Int Clin Psychopharmacol; 2016 Mar; 31(2):93-9. PubMed ID: 26544899
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytogenetic Effects of Chronic Methylphenidate Treatment and Chronic Social Stress in Adults with Attention-Deficit/Hyperactivity Disorder.
    Kittel-Schneider S; Spiegel S; Renner T; Romanos M; Reif A; Reichert S; Heupel J; Schnetzler L; Stopper H; Jacob C
    Pharmacopsychiatry; 2016 Jul; 49(4):146-54. PubMed ID: 26926233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD?
    Spencer TJ; Faraone SV; Biederman J; Lerner M; Cooper KM; Zimmerman B;
    J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):527-537. PubMed ID: 16670649
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Report of a 14-Year-Old Boy Whose Testosterone Level Decreased After Starting on Methylphenidate.
    Akaltun İ
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):181. PubMed ID: 26863036
    [No Abstract]   [Full Text] [Related]  

  • 67. Bone mineral density and turnover in children with attention-deficit hyperactivity disorder receiving methylphenidate.
    Lahat E; Weiss M; Ben-Shlomo A; Evans S; Bistritzer T
    J Child Neurol; 2000 Jul; 15(7):436-9. PubMed ID: 10921512
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The impact of discontinuing methylphenidate on weight and eating behavior.
    Benard V; Cottencin O; Guardia D; Vaiva G; Rolland B
    Int J Eat Disord; 2015 Apr; 48(3):345-8. PubMed ID: 24849706
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Antipsychotic agents and stimulants: a judicious combination?].
    de Jong MH; Eussen ML; van Gool AR
    Tijdschr Psychiatr; 2010; 52(1):57-61. PubMed ID: 20054798
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methylphenidate and growth in hyperactive children. A controlled withdrawal study.
    Klein RG; Landa B; Mattes JA; Klein DF
    Arch Gen Psychiatry; 1988 Dec; 45(12):1127-30. PubMed ID: 3058088
    [TBL] [Abstract][Full Text] [Related]  

  • 71. No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study.
    Huss M; Poustka F; Lehmkuhl G; Lehmkuhl U
    J Neural Transm (Vienna); 2008; 115(2):335-9. PubMed ID: 18253808
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.
    Pagerols M; Richarte V; Sánchez-Mora C; Garcia-Martínez I; Corrales M; Corominas M; Cormand B; Casas M; Ribasés M; Ramos-Quiroga JA
    Pharmacogenomics J; 2017 Jan; 17(1):98-104. PubMed ID: 26810137
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects.
    Biederman J; Spencer TJ; Monuteaux MC; Faraone SV
    J Pediatr; 2010 Oct; 157(4):635-40, 640.e1. PubMed ID: 20605163
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pulmonary arterial hypertension in an adolescent treated with methylphenidate.
    Karaman MG; Atalay F; Tufan AE; Erdogan A
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):229-31. PubMed ID: 20578938
    [No Abstract]   [Full Text] [Related]  

  • 75. Methylphenidate as a possible cause of thrombocytopenia.
    Kuperman AA; Yaniv I; Stahl B; Tamary H
    Ann Pharmacother; 2003; 37(7-8):1146. PubMed ID: 12841835
    [No Abstract]   [Full Text] [Related]  

  • 76. Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?
    Walitza S; Werner B; Romanos M; Warnke A; Gerlach M; Stopper H
    Environ Health Perspect; 2007 Jun; 115(6):936-40. PubMed ID: 17589603
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methylphenidate and somatic hallucinations.
    Rashid J; Mitelman S
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):945-946. PubMed ID: 17667474
    [No Abstract]   [Full Text] [Related]  

  • 78. Methylphenidate-Induced Nocturnal Bruxism Alleviated by Adjunctive Clonidine.
    Naguy A; Elsori D; Alamiri B
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):75-76. PubMed ID: 30575406
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Methylphenidate associated vitiligo in a child: A case report.
    Guler Aksu G; Akdere P; Toros F
    Asia Pac Psychiatry; 2019 Sep; 11(3):e12351. PubMed ID: 30821429
    [No Abstract]   [Full Text] [Related]  

  • 80. Lens opacities in children using methylphenidate hydrochloride.
    Duman NS; Duman R; Sarı Gökten E; Duman R
    Cutan Ocul Toxicol; 2017 Dec; 36(4):362-365. PubMed ID: 28376677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.